We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Solid performance by the net dialysis and related lab patient service segment is likely to have contributed to DaVita's (DVA) top line in the third quarter.
The healthcare is expected to witness substantial earnings growth of 5.1% in the third quarter, representing the second strongest sector this earnings season.
Bio-Rad (BIO) Q3 earnings are expected to have benefited from strong sales particularly within core PCR products, Droplet Digital PCR and Process Media.
HCA Healthcare's (HCA) third-quarter 2020 results are likely to reflect higher revenues owing to the gradual rise in patient volumes following the easing of government restrictions.
medical: Archive
Harrow Health (HROW) Enters Oversold Territory
by Zacks Equity Research
Harrow Health has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
HROW
medical
Clearside Biomedical (CLSD) Enters Oversold Territory
by Zacks Equity Research
Clearside Biomedical (CLSD) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
CLSD
medical
Align (ALGN) Unveils New Product for Better Treatment Option
by Zacks Equity Research
Align Technology's (ALGN) latest product to aid in improving doctor performance and ensure better treatment planning.
XRAY ALGN HSIC SAUHF
medical
DaVita (DVA) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Solid performance by the net dialysis and related lab patient service segment is likely to have contributed to DaVita's (DVA) top line in the third quarter.
DVA CAH MASI IDXX
medical
New Strong Sell Stocks for October 26th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
DRQ EFSC FMAO ODT DKNG
consumer-discretionary finance medical oil-energy
NextGen Healthcare (NXGN) Gains 8.1% Post Q2 Earnings Beat
by Zacks Equity Research
NextGen (NXGN) benefited from both its operating segments in Q2.
RMD IDXX PODD NXGN
earnings medical
HCA Healthcare (HCA) Q3 Earnings Miss Estimates, Down Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) third-quarter results reflect decline in admissions, partly offset by higher revenues.
UNH ALXN THC HCA
earnings medical
LabCorp (LH) Extends Pact With Swedish for Coronavirus Lab Service
by Zacks Equity Research
Under the extended alliance, LabCorp (LH) expects to expand its COVID-19 test capacity in the Seattle area.
BDX DGX LH TMO
medical
Anthem (ANTM) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Anthem's (ANTM) third-quarter earnings results are likely to reflect elevated costs and a softness in Commercial business line.
SEM ANTM CGC BHC
medical
Will Covid-Led Higher Demand Aid Teladoc's (TDOC) Q3 Earnings?
by Zacks Equity Research
A surge in demand for virtual health care services is likely to have contributed to Teladoc's (TDOC) earnings in Q3
GILD SEM TDOC CDNA
medical
Livongo Health (LVGO) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Livongo Health's (LVGO) third-quarter results are likely to reflect growth in core Livongo for Diabetes solution.
PACB GWPH ZBH LVGO
earnings medical
Baxter (BAX) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Baxter's (BAX) third-quarter performance is likely to reflect growth in its Acute Therapies business.
BAX PACB GWPH ZBH
earnings medical
Stryker (SYK) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Stryker's (SYK) third-quarter results are likely to reflect weak segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine.
SYK PACB GWPH ZBH
earnings medical
New Strong Buy Stocks for October 26th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.
RUSHA HZO FSTR DVA CVLG
auto-tires-trucks consumer-discretionary medical retail transportation
Top Ranked Value Stocks to Buy for October 26th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, October 26th.
HZO FRO DHC
consumer-discretionary medical retail transportation
Top Research Reports for AMD, Workday & Moody's
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including Advanced Micro Devices (AMD), Workday (WDAY) and Moody's (MCO).
WDAY STT MCO IDXX ERIC AMD
communications computers medical semiconductor
Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus
by Sweta Killa
The healthcare is expected to witness substantial earnings growth of 5.1% in the third quarter, representing the second strongest sector this earnings season.
JNJ PFE GILD MRK LLY BMY AMGN ABBV XLV VHT IYH FHLC
earnings etfs medical
What's in Store for IDEXX Laboratories (IDXX) in Q3 Earnings?
by Zacks Equity Research
IDEXX's (IDXX) third-quarter top line is likely to have benefited from strength in CAG and LPD businesses.
CAH QDEL LHCG IDXX
medical
Illumina (ILMN) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Illumina (ILMN) is upbeat about its third-quarter sequencing consumable revenue growth.
ILMN CAH QDEL IDXX
biotechs medical
Bio-Rad (BIO) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Bio-Rad (BIO) Q3 earnings are expected to have benefited from strong sales particularly within core PCR products, Droplet Digital PCR and Process Media.
HUM LHCG BIO IDXX
earnings medical
Boston Scientific (BSX) Q3 Earnings to Grow on Vital Procedures
by Zacks Equity Research
Boston Scientific's (BSX) Q3 sales are expected to have benefited from growing demand for less-deferrable procedures across most of the segments.
HUM BSX LHCG IDXX
earnings medical
Centene (CNC) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Centene's (CNC) Q3 results are likely to reflect benefits from growing revenues and improving membership.
AMGN CNC TDOC AXLA
medical
New Strong Sell Stocks for October 23rd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
EEFT ALK GLNG DKL RLMD
airlines finance medical oil-energy transportation
HCA Healthcare (HCA) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
HCA Healthcare's (HCA) third-quarter 2020 results are likely to reflect higher revenues owing to the gradual rise in patient volumes following the easing of government restrictions.
ALXN HCA HZNP TDOC
medical
Top Analyst Reports for Netflix, Lockheed Martin & Zoetis
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including Netflix (NFLX), Lockheed Martin (LMT) and Zoetis (ZTS).
ZTS TEAM NFLX MRNA LMT ITUB
aerospace finance internet medical